Point72 Hong Kong LTD Enanta Pharmaceuticals Inc Transaction History

Point72 Hong Kong LTD

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $29,167 - $43,047	604 Added 38.59%	2,169 $113,000
Q2 2022 Aug 15, 2022	BUY	$38.13 - $76.93 $27,186 - $54,851	713 Added 83.69%	1,565 $74,000
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $37,952 - $50,172	-677 Reduced 44.28%	852 $61,000
Q4 2021 Feb 14, 2022	BUY	$60.19 - $97.37 $92,030 - $148,878	1,529 New	1,529 $114,000
Q2 2021 Aug 16, 2021	SELL	$43.76 - $53.11 $20,610 - $25,014	-471 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $19,635 - $25,881	471 New	471 $23,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $35,109 - $40,491	-853 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $3,468 - $4,282	-80 Reduced 8.57%	853 $39,000
Q2 2020 Aug 14, 2020	BUY	$46.37 - $57.58 $43,263 - $53,722	933 New	933 $47,000
Q3 2019 Nov 14, 2019	SELL	$60.08 - $88.17 $9,012 - $13,225	-150 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $11,463 - $13,726	141 Added 1566.67%	150 $13,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $621 - $950	9 New	9 $1,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $1,308 - $1,693	-20 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$85.46 - $126.37 $1,709 - $2,527	20 New	20 $2,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.